过敏性真菌鼻炎:我们可以从过敏性支气管肺部菌中学到什么
Tsuguhisa Nakayama1, Jun Miyata2, Natsuki Inoue3
1Department of Otorhinolaryngology and Head & Neck Surgery, Dokkyo Medical University, Tochigi, Japan.
概括
过敏性真菌鼻炎 (AFRS) 和过敏性支气管肺部菌 (ABPM) 具有相似的炎症途径,但在患者人口统计和临床表现方面有所不同. 了解ABPM可以提供对AFRS病原学的见解.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 过敏性真菌鼻炎 (AFRS) 和过敏性支气管肺部菌 (ABPM) 是一种炎症性呼吸道疾病.
- 这两种情况都是由于对真菌的过敏反应引起的,其特点是异osinophil 透和粘液过分分泌.
- 病理机制包括eosinophilic粘素引起组织损伤,如骨质侵蚀在AFRS和支气管在ABPM.
研究的目的:
- 为了澄清AFRS和ABPM病变发生的相似之处和差异.
- 通过利用来自更广泛研究的ABPM的知识来探索对AFRS的潜在见解.
主要方法:
- 对AFRS和ABPM现有文献的比较综述.
- 对这两种疾病的流行病学,临床和免疫学数据的分析.
主要成果:
- AFRS通常影响年轻患者,喘不那么严重,IgE水平低于ABPM.
- 尽管有共同的发病因子,但在这两种疾病中,协同发生的突突过敏菌是罕见的,突出区别.
- 氨酸性粘素是上空气道 (AFRS) 和下空气道 (ABPM) 的不同病理的一个关键因素.
结论:
- 虽然AFRS和ABPM共享炎症途径,但它们具有独特的流行病学和临床特征.
- 进一步比较这些情况的研究可能会揭示真菌诱导的呼吸道炎症的具体治疗点.
更多相关视频
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
499
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
499
Asthma: Pathogenesis and Management
450
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
450
Drugs Used in Upper Respiratory Disorders: Overview
292
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
292
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
308
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
308
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Cystic Fibrosis: Management
195
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
195


